Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data

• Päätekijät: Stephen M. Stahl (Tekijä), Sarah Laredo (Tekijä), Debbi Ann Morrissette (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: SAGE Publishing, 2020-02-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Cariprazine is one of the newest dopamine-serotonin partial agonists, also known as 'atypical' second generation antipsychotics. Originally approved for acute and maintenance treatment of schizophrenia as well as for acute mania and mixed mania/depression, cariprazine has now been approved...